JP2022513075A5 - - Google Patents
Info
- Publication number
- JP2022513075A5 JP2022513075A5 JP2021527115A JP2021527115A JP2022513075A5 JP 2022513075 A5 JP2022513075 A5 JP 2022513075A5 JP 2021527115 A JP2021527115 A JP 2021527115A JP 2021527115 A JP2021527115 A JP 2021527115A JP 2022513075 A5 JP2022513075 A5 JP 2022513075A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- trans
- peptide containing
- peptide
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862769281P | 2018-11-19 | 2018-11-19 | |
| US62/769,281 | 2018-11-19 | ||
| PCT/US2019/061928 WO2020106598A1 (en) | 2018-11-19 | 2019-11-18 | Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513075A JP2022513075A (ja) | 2022-02-07 |
| JP2022513075A5 true JP2022513075A5 (enExample) | 2023-01-10 |
Family
ID=70773408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527115A Pending JP2022513075A (ja) | 2018-11-19 | 2019-11-18 | タウオパチーの処置のための、タウペプチド抗原およびそれに結合する抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220273779A1 (enExample) |
| EP (1) | EP3883602A4 (enExample) |
| JP (1) | JP2022513075A (enExample) |
| CN (1) | CN113490505A (enExample) |
| WO (1) | WO2020106598A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10501531B2 (en) | 2013-03-13 | 2019-12-10 | Prothena Biosciences Limited | Tau immunotherapy |
| PT3452507T (pt) | 2016-05-02 | 2022-12-20 | Prothena Biosciences Ltd | Imunoterapia anti-tau |
| MY198194A (en) | 2016-05-02 | 2023-08-09 | Prothena Biosciences Ltd | Antibodies Recognizing Tau |
| KR102784294B1 (ko) | 2017-05-02 | 2025-03-19 | 프로테나 바이오사이언시즈 리미티드 | 타우 인식 항체 |
| CA3079236A1 (en) * | 2017-10-27 | 2019-05-02 | United Neuroscience | Tau peptide immunogen constructs |
| JP7630834B2 (ja) | 2019-03-03 | 2025-02-18 | プロセナ バイオサイエンシーズ リミテッド | タウ認識抗体 |
| CN113861441A (zh) * | 2021-10-28 | 2021-12-31 | 南开大学 | 一种tau蛋白特异的纳米分子伴侣的制备方法及其在抑制tau聚集中的应用 |
| CN114113278B (zh) * | 2021-11-24 | 2024-08-02 | 中国计量科学研究院 | 一种基于质谱的体外诊断试剂抗体的表位定位方法 |
| CN116554342A (zh) * | 2022-01-29 | 2023-08-08 | 元本(珠海横琴)生物科技有限公司 | 一种融合表达Tau-4R蛋白的大肠杆菌工程菌株 |
| JP2023175325A (ja) * | 2022-05-30 | 2023-12-12 | 学校法人順天堂 | タウオパチーの鑑別診断法 |
| CN116549632B (zh) * | 2023-03-28 | 2024-09-10 | 中国人民解放军军事科学院军事医学研究院 | 抗Lingo-1抗体Opicinumab的新用途及针对新用途的药物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0618968T3 (da) * | 1991-12-06 | 2000-04-10 | Max Planck Gesellschaft | Midler til diagnostisering og behandling af Alzheimer's sygdom |
| US8012936B2 (en) * | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| CN106390107B (zh) * | 2009-06-10 | 2019-12-31 | 纽约大学 | 病理tau蛋白的免疫靶向 |
| ME03008B (me) * | 2011-09-19 | 2018-10-20 | Axon Neuroscience Se | Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti |
-
2019
- 2019-11-18 EP EP19887369.7A patent/EP3883602A4/en not_active Withdrawn
- 2019-11-18 CN CN201980089304.0A patent/CN113490505A/zh active Pending
- 2019-11-18 JP JP2021527115A patent/JP2022513075A/ja active Pending
- 2019-11-18 WO PCT/US2019/061928 patent/WO2020106598A1/en not_active Ceased
- 2019-11-18 US US17/295,152 patent/US20220273779A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513075A5 (enExample) | ||
| JP6858182B2 (ja) | インターロイキン３３（ｉｌ−３３）媒介疾患に関するバイオマーカーおよびその使用 | |
| CN108290058B (zh) | 使用il23途径生物标志物预测il23拮抗剂的临床应答 | |
| JP2022541652A5 (enExample) | ||
| JP4851348B2 (ja) | 抗Ａβ抗体 | |
| JP2020510081A (ja) | 抗Ｎ３ｐＧｌｕアミロイドベータペプチド抗体およびその使用 | |
| JP2017113004A5 (enExample) | ||
| WO2011100637A1 (en) | Markers for determination of patient responsiveness | |
| CN108700589A (zh) | 用于检测和治疗食管癌的组合物和方法 | |
| CN112961222A (zh) | 2019新型冠状病毒n蛋白线性表位肽和单克隆抗体及应用 | |
| JP2009536818A5 (enExample) | ||
| CN108780091A (zh) | 用于检测和治疗卵巢癌的组合物和方法 | |
| CN108472367A (zh) | 作为对il23拮抗剂的临床应答的预测因子的ccl20 | |
| CN105899231A (zh) | 用于在具有升高水平的tlr4配体和其它生物标记的患者中诊断和治疗病症的方法和组合物 | |
| TW202206458A (zh) | 靶向介白素-34之化合物及方法 | |
| TWI734279B (zh) | 抗α-突觸核蛋白抗體及其用途 | |
| CN111065651A (zh) | Il-5抗体、其抗原结合片段及医药用途 | |
| KR102558891B1 (ko) | 항―ｉｌ４―ｉｌ１３ ２특이성 항체 | |
| JP2022542699A5 (enExample) | ||
| CN117106068A (zh) | 抗水痘-带状疱疹病毒的抗体 | |
| JP6965157B2 (ja) | Ｈ因子を強化する抗体及びその用途 | |
| CN118206657B (zh) | 一种半乳糖凝集素-3的抗体及其应用 | |
| Kobayashi et al. | Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan | |
| CN110418805B (zh) | 用于在肝病的治疗中使用的抗ccl24(嗜酸性粒细胞趋化因子2)抗体 | |
| US10351630B2 (en) | Assay to detect human DPP-4 |